Miles McPherson – Trademark Portfolio
Entity Type: 01
Miles McPherson holds 10 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 41 (Education & Entertainment) — 9 filings in this category. The portfolio also extends into Class 45 (Legal & Security Services) across 3 Nice Classification classes. Currently, 3 trademarks are registered and 5 are pending. Notable registered marks include JUST1, THE THIRD OPTION, and SIMILARITY TRAINING. The owner is based in San Diego, CA.
11360 Mandrake Point
San Diego, CA 92131
Showing of trademarks Trademarks
Trademark Classifications
Miles McPherson's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Education; providing of training; entertainment; sporting and cultural activities
Legal services; security services for the protection of property and individuals
Advertising; business management; business administration; office functions
Frequently Asked Questions
How many trademarks does Miles McPherson have?
Miles McPherson has 10 U.S. trademarks filed with the USPTO. Of these, 3 registered, 5 pending, 2 abandoned.
What trademark classes does Miles McPherson file in?
Miles McPherson files trademarks across 3 Nice Classification classes. The most active classes are Class 41 (Education & Entertainment), Class 45 (Legal & Security Services), Class 35 (Advertising & Business). Class 41 covers education; providing of training; entertainment; sporting and cultural activities.
What are Miles McPherson's most well-known trademarks?
Miles McPherson's registered trademark portfolio includes well-known marks such as JUST1, THE THIRD OPTION, and SIMILARITY TRAINING. These are among 3 currently registered trademarks in the portfolio.
What is Miles McPherson's trademark registration success rate?
Miles McPherson has a 60% trademark registration rate, with 3 out of 5 resolved applications resulting in successful registration. Currently, 5 applications are pending review.